November 28, 2018

Optellum selected for TMCx Accelerator at the world’s largest medical complex

Texas Medical Center

The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend 4 months building our business with industry and clinical experts and mentors inside Texas Medical Center, the largest medical complex in the world.

The multidisciplinary team of experts from across the Texas Medical Center and the country reviewed more than 200 digital health solutions from around the world. They were impressed by the competitive pool and carefully considered multiple factors for each application, including innovativeness and strength of the technology, business model, market size, customer traction, and overall fit for the TMCx program.

TMCx is a program designed to meet the needs of startups at every stage while reducing barriers of access to hospital stakeholders and key opinion leaders across the Texas Medical Centre, which houses 54 medical institution, including the University of Texas M.D. Anderson Cancer Center, the No 1 cancer hospital in the world.

The program culminates on Thursday, June 6, 2019, with TMCx Demo Day, a closing ceremony where the Optellum team will pitch to over 400 investors, clinical experts, and industry leaders, with over a 1,000 more viewing remotely over the internet.

Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow
SimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...
Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...
Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us